Inventor · disambiguated record
Glenn A. Goldstein
Also filed as: GOLDSTEIN GLENN · GOLDSTEIN GLENN A
12 granted patents·16 pending applications·260 citations·filing 1982–2023
92Inventor score
Files withGOLDSTEIN GLENN A18SENTIENT LIFESCIENCES INC5VIACOM INT INC2GOLDSTEIN GLENN1GRIFFIN BRIAN1
Top patents by PatentIndex Score
28 records- 0196US9216162B2N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2015·Granted Dec 22, 2015·13 cites·25 claims
- 0293US10869846B2N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2018·Granted Dec 22, 2020·5 cites·15 claims
- 0393USD273472SEarringGOLDSTEIN GLENN·Filed 1982·Granted Apr 17, 1984·51 cites·1 claims
- 0491US8993627B2N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stressSENTIENT LIFESCIENCES INC·Filed 2013·Granted Mar 31, 2015·9 cites·8 claims
- 0591US8937099B2N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2010·Granted Jan 20, 2015·15 cites·21 claims
- 0690US8354449B2N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2010·Granted Jan 15, 2013·14 cites·8 claims
- 0790US5240308AErgonomic adjustable chair and methodGOLDSTEIN GLENN A·Filed 1991·Granted Aug 31, 1993·95 cites·4 claims
- 0881US10165316B2Device, system, and method for hybrid media content distributionVIACOM INT INC·Filed 2016·Granted Dec 25, 2018·3 cites·18 claims
- 0978US5018786AErgonomic adjustable chair and methodGOLDSTEIN GLENN A·Filed 1987·Granted May 28, 1991·52 cites·10 claims
- 1071US12452333B2Enhanced management of egress traffic to a peer communications networkLEVEL 3 COMMUNICATIONS LLC·Filed 2023·Granted Oct 21, 2025·0 cites·18 claims
- 1168US8929718B2Systems and methods for providing online advertisementsGRIFFIN BRIAN·Filed 2011·Granted Jan 6, 2015·3 cites·18 claims
- 1265US2017135970A1N-acetylcysteine amide (nac amide) in the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2016·Application pending·0 cites
- 1363US2016206576A1N-acetylcysteine amide (nac amide) in the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2015·Application pending·0 cites
- 1463US2020170968A1Use of N-Acetylcysteine Amide in the Treatment of Acquired Immune Deficiency Syndrome and HIV InfectionGOLDSTEIN GLENN A·Filed 2019·Application pending·0 cites
- 1562US2020069617A1Use of n-acetylcysteine amide in the treatment of acetaminophen overdoseGOLDSTEIN GLENN A·Filed 2019·Application pending·0 cites
- 1659US2019151262A1Use of n-acetylcysteine amide for decreasing intracranial pressureGOLDSTEIN GLENN A·Filed 2018·Application pending·0 cites
- 1758US2019388369A1Use of N-acetylcysteine Amide in the Treatment Of Disease and InjurySENTIENT LIFESCIENCES INC·Filed 2019·Application pending·0 cites
- 1856US10547886B2Device, system, and method for hybrid media content distributionVIACOM INT INC·Filed 2018·Granted Jan 28, 2020·0 cites·16 claims
- 1955US2009234011A1N-acetylcysteine amide (nac amide) for the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2006·Application pending·0 cites
- 2055US2015148423A1Use of n-acetylcysteine amide in the treatment of disease and injurySENTIENT LIFESCIENCES INC·Filed 2013·Application pending·0 cites
- 2153US2008274888A1N-Acetylcysteine Amide (Nac Amide) for Enhancing Plant Resistance and Tolerance to Environmental StressGOLDSTEIN GLENN A·Filed 2006·Application pending·0 cites
- 2253US2015133558A1Use of n-acetylcysteine amide for decreasing intracranial pressureGOLDSTEIN GLENN A·Filed 2014·Application pending·0 cites
- 2353US2017000747A1Use of n-acetylcysteine amide in the treatment of acetaminophen overdoseGOLDSTEIN GLENN A·Filed 2016·Application pending·0 cites
- 2451US2008200548A1N-Acetylcysteine Amide (Nac Amide) for Treatment of Oxidative Stress Associated with InfertilityGOLDSTEIN GLENN A·Filed 2006·Application pending·0 cites
- 2549US2015038586A1Use of n-acetylcysteine amide in the treatment of penetrating head injurySENTIENT LIFESCIENCES INC·Filed 2014·Application pending·0 cites
- 2648US2020038349A1Use of n-acetylcysteine amide in the treatment of penetrating head injurySENTIENT LIFESCIENCES INC·Filed 2019·Application pending·0 cites
- 2742US2010137676A1N-acetylcysteine amide (nac amide) for treatment of oxidative stress associated with infertilityGOLDSTEIN GLENN A·Filed 2010·Application pending·0 cites
- 2840US2017049727A1Use of N-Acetylcysteine Amide in the Treatment of Acquired Immune Deficiency Syndrome and HIV InfectionGOLDSTEIN GLENN A·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Glenn A. Goldstein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →